QQQ   290.39 (+0.00%)
AAPL   113.85 (-2.97%)
MSFT   210.11 (-0.13%)
FB   268.43 (-0.47%)
GOOGL   1,727.56 (-0.51%)
AMZN   3,098.39 (-0.03%)
TSLA   521.85 (+6.58%)
NVDA   525.60 (+0.40%)
BABA   270.11 (-0.23%)
CGC   24.72 (+4.22%)
GE   10.07 (+3.18%)
MU   64.18 (+4.53%)
AMD   85.31 (+0.79%)
T   28.62 (+1.06%)
NIO   55.38 (+12.45%)
F   8.86 (+1.37%)
ACB   7.18 (+0.70%)
GILD   59.89 (-0.37%)
NFLX   476.62 (-2.38%)
BA   211.53 (+5.97%)
DIS   145.98 (+3.48%)
QQQ   290.39 (+0.00%)
AAPL   113.85 (-2.97%)
MSFT   210.11 (-0.13%)
FB   268.43 (-0.47%)
GOOGL   1,727.56 (-0.51%)
AMZN   3,098.39 (-0.03%)
TSLA   521.85 (+6.58%)
NVDA   525.60 (+0.40%)
BABA   270.11 (-0.23%)
CGC   24.72 (+4.22%)
GE   10.07 (+3.18%)
MU   64.18 (+4.53%)
AMD   85.31 (+0.79%)
T   28.62 (+1.06%)
NIO   55.38 (+12.45%)
F   8.86 (+1.37%)
ACB   7.18 (+0.70%)
GILD   59.89 (-0.37%)
NFLX   476.62 (-2.38%)
BA   211.53 (+5.97%)
DIS   145.98 (+3.48%)
QQQ   290.39 (+0.00%)
AAPL   113.85 (-2.97%)
MSFT   210.11 (-0.13%)
FB   268.43 (-0.47%)
GOOGL   1,727.56 (-0.51%)
AMZN   3,098.39 (-0.03%)
TSLA   521.85 (+6.58%)
NVDA   525.60 (+0.40%)
BABA   270.11 (-0.23%)
CGC   24.72 (+4.22%)
GE   10.07 (+3.18%)
MU   64.18 (+4.53%)
AMD   85.31 (+0.79%)
T   28.62 (+1.06%)
NIO   55.38 (+12.45%)
F   8.86 (+1.37%)
ACB   7.18 (+0.70%)
GILD   59.89 (-0.37%)
NFLX   476.62 (-2.38%)
BA   211.53 (+5.97%)
DIS   145.98 (+3.48%)
QQQ   290.39 (+0.00%)
AAPL   113.85 (-2.97%)
MSFT   210.11 (-0.13%)
FB   268.43 (-0.47%)
GOOGL   1,727.56 (-0.51%)
AMZN   3,098.39 (-0.03%)
TSLA   521.85 (+6.58%)
NVDA   525.60 (+0.40%)
BABA   270.11 (-0.23%)
CGC   24.72 (+4.22%)
GE   10.07 (+3.18%)
MU   64.18 (+4.53%)
AMD   85.31 (+0.79%)
T   28.62 (+1.06%)
NIO   55.38 (+12.45%)
F   8.86 (+1.37%)
ACB   7.18 (+0.70%)
GILD   59.89 (-0.37%)
NFLX   476.62 (-2.38%)
BA   211.53 (+5.97%)
DIS   145.98 (+3.48%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Biohaven PharmaceuticalAmicus TherapeuticsBridgeBio PharmaEmergent BioSolutionsArena Pharmaceuticals
SymbolNYSE:BHVNNASDAQ:FOLDNASDAQ:BBIONYSE:EBSNASDAQ:ARNA
Price Information
Current Price$88.48$22.39$46.44$79.67$64.68
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.21.21.41.81.7
Analysis Score1.42.41.32.44.5
Community Score2.43.02.32.72.4
Dividend Score0.00.00.00.00.0
Ownership Score1.70.02.51.71.7
Earnings & Valuation Score0.60.60.62.50.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$84.20$21.35$47.40$93.17$90.36
% Upside from Price Target-4.84% downside-4.64% downside2.07% upside16.94% upside39.70% upside
Trade Information
Market Cap$5.30 billion$5.83 billion$5.69 billion$4.22 billion$3.76 billion
Beta1.121.470.341.441.16
Average Volume792,0372,788,922733,848645,185685,780
Sales & Book Value
Annual RevenueN/A$182.24 million$40.56 million$1.11 billion$806.43 million
Price / SalesN/A32.02140.343.824.67
CashflowN/AN/AN/A$4.73 per share$7.87 per share
Price / CashN/AN/AN/A16.838.22
Book Value($3.57) per share$1.87 per share$1.76 per share$23.61 per share$20.11 per share
Price / BookN/A11.9726.393.373.22
Profitability
Net Income$-528,800,000.00$-356,390,000.00$-260,590,000.00$54.50 million$397.55 million
EPS($10.91)($1.31)($2.48)$2.91$7.69
Trailing P/E RatioN/AN/AN/A25.62N/A
Forward P/E RatioN/AN/AN/A8.99N/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-129.10%N/A12.50%-5,727.22%
Return on Equity (ROE)-1,091.41%-65.53%-109.88%26.68%-33.17%
Return on Assets (ROA)-120.85%-36.94%-48.54%12.70%-30.41%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.42%2.19%0.68%0.04%
Current Ratio3.26%3.54%9.85%3.20%23.17%
Quick Ratio3.17%3.42%9.85%2.30%23.17%
Ownership Information
Institutional Ownership Percentage94.49%N/A94.35%73.00%79.94%
Insider Ownership Percentage19.10%2.50%40.32%14.10%3.05%
Miscellaneous
Employees6475842481,834320
Shares Outstanding59.94 million260.59 million122.57 million53.00 million58.16 million
Next Earnings Date2/23/2021 (Estimated)3/1/2021 (Estimated)3/1/2021 (Estimated)2/18/2021 (Estimated)2/24/2021 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.